Works matching DE "CANAGLIFLOZIN"

Results: 688

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.

Published in:

2020

By:

Musso, Giovanni;
Sircana, Antonio;
Saba, Francesca;
Cassader, Maurizio;
Gambino, Roberto

Publication type:

journal article

Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis.

Published in:

Acta Diabetologica, 2023, v. 60, n. 10, p. 1311, doi. 10.1007/s00592-023-02126-8

By:

Hegde, Naveen C.;
Kumar, Ankit;
Patil, Amol N.;
Bhattacharjee, Samiksha;
Gamad, Nanda;
Kasudhan, Kripa Shanker;
Kumar, Vivek;
Rastogi, Ashu

Publication type:

Article

Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.

Published in:

Acta Diabetologica, 2020, v. 57, n. 7, p. 809, doi. 10.1007/s00592-020-01487-8

By:

Rastogi, Ashu;
Dunbar, Richard L.;
Thacker, Hemant P.;
Bhatt, Jayesh;
Parmar, Krupi;
Parmar, Deven V.

Publication type:

Article

Impact of variations in duodenal glucose load on insulin clearance in health and type 2 diabetes.

Published in:

Acta Diabetologica, 2018, v. 55, n. 2, p. 205, doi. 10.1007/s00592-017-1073-z

By:

Marathe, Chinmay S.;
Rayner, Christopher K.;
Jones, Karen L.;
Horowitz, Michael

Publication type:

Article

Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials.

Published in:

Acta Diabetologica, 2017, v. 54, n. 4, p. 411, doi. 10.1007/s00592-016-0928-z

By:

Monami, Matteo;
Zannoni, Stefania;
Nreu, Besmir;
Mannucci, Edoardo

Publication type:

Article

Finerenone in SGLT-2 Inhibitors Era: Current Positioning in Diabetic Kidney Disease.

Published in:

Clinical Diabetology, 2022, v. 11, n. 6, p. 357, doi. 10.5603/DK.a2022.0041

By:

Singh, Awadhesh Kumar;
Singh, Ritu;
Shah, Viral N.;
Misra, Anoop

Publication type:

Article

Survey to Specify SGLT2 Inhibitor Choice in T2DM Management.

Published in:

Clinical Diabetology, 2022, v. 11, n. 5, p. 326, doi. 10.5603/DK.a2022.0042

By:

Ghosal, Samit;
Joshi, Radhika M.;
Iyer, Rahul N.;
Adsule, Samir M.

Publication type:

Article

Harmful versus beneficial effects of using short-term combined oral antidiabetic therapy: An open-label comparative clinical trial.

Published in:

Clinical Diabetology, 2021, v. 10, n. 4, p. 349

By:

Baito, Qoyama N.;
Alhassani, Ansam N.;
Al-Nimer, Marwan S. M.

Publication type:

Article

Glycaemic and weight-loss outcomes of graded doses of canagliflozin in type 2 diabetes -- a real-world study.

Published in:

Clinical Diabetology, 2020, v. 9, n. 6, p. 442, doi. 10.5603/DK.2020.0044

By:

Dutta, Deep;
Sharma, Meha;
Dhall, Anil;
Aggarwal, Sameer;
Khandelwal, Deepak

Publication type:

Article

A real-world retrospective evaluation of glycaemic control and weight loss in patients with type 2 diabetes mellitus treated with canagliflozin 100 mg and canagliflozin 300 mg in an Indian setting.

Published in:

Clinical Diabetology, 2020, v. 9, n. 5, p. 300, doi. 10.5603/DK.2020.0031

By:

Mukherjee, Poulomi;
Roychoudhury, Soumyabrata;
Majumder, Anirban

Publication type:

Article

Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin.

Published in:

GeroScience, 2024, v. 46, n. 5, p. 4657, doi. 10.1007/s11357-024-01176-2

By:

Miller, Richard A.;
Harrison, David E.;
Cortopassi, Gino A.;
Dehghan, Ishmael;
Fernandez, Elizabeth;
Garratt, Michael;
Geisler, John G.;
Ginsburg, Brett C.;
Han, Melissa L.;
Kaczorowski, Catherine C.;
Kumar, Navasuja;
Leiser, Scott F.;
Lopez-Cruzan, Marisa;
Milne, Ginger;
Mitchell, James R.;
Nelson, James F.;
Reifsnyder, Peter C.;
Salmon, Adam B.;
Korstanje, Ron;
Rosenthal, Nadia

Publication type:

Article

Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice.

Published in:

GeroScience, 2023, v. 45, n. 1, p. 385, doi. 10.1007/s11357-022-00641-0

By:

Snyder, Jessica M.;
Casey, Kerriann M.;
Galecki, Andrzej;
Harrison, David E.;
Jayarathne, Hashan;
Kumar, Navasuja;
Macchiarini, Francesca;
Rosenthal, Nadia;
Sadagurski, Marianna;
Salmon, Adam B.;
Strong, Randy;
Miller, Richard A.;
Ladiges, Warren

Publication type:

Article

Neuroprotective effect of canagliflozin against cisplatin-induced cerebral cortex injury is mediated by regulation of HO-1/PPAR-γ, SIRT1/FOXO-3, JNK/AP-1, TLR4/iNOS, and Ang II/Ang 1–7 signals.

Published in:

Immunopharmacology & Immunotoxicology, 2023, v. 45, n. 3, p. 304, doi. 10.1080/08923973.2022.2143371

By:

Hassanein, Emad H. M.;
Saleh, Fayez M.;
Ali, Fares E. M.;
Rashwan, Eman K.;
Atwa, Ahmed M.;
Abd El-Ghafar, Omnia A. M.

Publication type:

Article

A study of canagliflozin on post prandial blood sugar control.

Published in:

Indian Journal of Basic & Applied Medical Research, 2021, v. 10, n. 3, p. 18, doi. 10.36848/IJBAMR/2020/29215.55560

By:

P., SAI SEKHAR;
RONGALI, APPALA NAIDU

Publication type:

Article

Analytical Quality by Design Assisted HPLC Method for Quantification of Canagliflozin/Metformin and Stability Studies.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2019, v. 53, p. S699, doi. 10.5530/ijper.53.4s.167

By:

Gurrala, Sunitha;
Shivaraj;
Subrahmanyam, C. V. S.;
Anumolu, Panikumar Durga;
Saraf, Gowthami

Publication type:

Article

Simultaneous Determination of Canagliflozin and Metformin in Human Plasma by LC--MS/MS Assay and its Application to a Human Pharmacokinetic Study.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2019, v. 53, p. S364, doi. 10.5530/ijper.53.3s.107

By:

Ramisetti, Muralikrishna;
Atmakuri, Lakshmana Rao;
Venkata, Basaveswara Rao Mandava;
Adireddy, Vinayender

Publication type:

Article

Formulation, Optimization and Evaluation of in-situ Gelling Liquid Oral Formulation of a Novel Antidiabetic Drug: Canagliflozin.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2019, v. 53, p. S121, doi. 10.5530/ijper.53.2s.56

By:

Bhatta, Rohith Ganapathi;
Rudragangaiah, Sadashivaiah;
Kotappa, Satheesha Babu Birur

Publication type:

Article

Predictive Modeling of Factors Influencing Adherence to SGLT-2 Inhibitors in Ambulatory Care: Insights from Prescription Claims Data Analysis.

Published in:

Pharmacy, 2024, v. 12, n. 2, p. 72, doi. 10.3390/pharmacy12020072

By:

Khartabil, Nadia;
Morello, Candis M.;
Macedo, Etienne

Publication type:

Article

Heterogenous expression of endocrine and progenitor cells within the neonatal porcine pancreatic lobes–Implications for neonatal porcine islet xenotransplantation.

Published in:

Xenotransplantation, 2023, v. 30, n. 2, p. 1, doi. 10.1111/xen.12793

By:

Seeberger, Karen L;
Salama, Bassem F;
Kelly, Sandra;
Rosko, Mandy;
Castro, Chelsea;
DesAulniers, Jessica;
Korbutt, Gregory S

Publication type:

Article

Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes.

Published in:

Pediatric Diabetes, 2018, v. 19, n. 4, p. 649, doi. 10.1111/pedi.12626

By:

Tamborlane, William V.;
Polidori, David;
Argenti, Domenick;
Di Prospero, Nicholas A.

Publication type:

Article

Características diferenciales del empagliflozin en el tratamiento de la diabetes mellitus.

Published in:

Revista Latinoamericana de Hipertension, 2021, v. 16, n. 2, p. 163, doi. 10.5281/zenodo.5514033

By:

Aguilera Moreira, Vicente David;
Mendieta González, María Dennys;
López Pino, Adriana Victoria;
Tapia Mena, David Sebastián;
Caisa Villacrés, Virginia Zeneida;
Revelo Benavides, Karen Michel;
Araujo Egas, Carla María;
Santamaría Loza, Estefanía Carolina;
Velásquez Gutiérrez, Abraham Melquisedec

Publication type:

Article

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1366439

By:

Alsalem, Abdulaziz;
Alsultan, Mohammed M.;
Alqarni, Faisal;
Almangour, Abdullah;
Alsharekh, Lolwa;
Alenazi, Saleem;
Alzahrani, Saleh;
Almanqour, Raghad A.;
Alazmi, Abdullah;
Alzahrani, Abdullah

Publication type:

Article

Emerging role of antidiabetic drugs in cardiorenal protection.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1349069

By:

Wen-Jia Fu;
Jin-Ling Huo;
Zi-Hui Mao;
Shao-Kang Pan;
Dong-Wei Liu;
Zhang-Suo Liu;
Peng Wu;
Zhong-Xiuzi Gao

Publication type:

Article

Modeling the protein binding nonlinearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1228641

By:

Lina Zhang;
Maochang Liu;
Weiwei Qin;
Dandan Shi;
Junjun Mao;
Zeyun Li

Publication type:

Article

Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1152611

By:

Jian Wang;
Xin Lv;
A-Shan-Jiang A-Ni-Wan;
Sha-Sha Tian;
Jun-Mei Wang;
Hong-Yan Liu;
Xiao-Guang Fan;
Sai-Jun Zhou;
Pei Yu

Publication type:

Article

Canagliflozin, an inhibitor of sodium-glucose co-transporter 2, advances in the treatment of type 2 diabetes.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 8, p. 569, doi. 10.5246/jcps.2022.08.049

By:

Ying Fu;
Simo Liu;
Yan Ma;
Nannan Wu

Publication type:

Article

Canagliflozin ameliorates ferritinophagy in HFpEF rats.

Published in:

Journal of Geriatric Cardiology, 2025, v. 22, n. 1, p. 178, doi. 10.26599/1671-5411.2025.01.006

By:

Sai MA;
Qing-Juan ZUO;
Li-Li HE;
Guo-Rui ZHANG;
Ting-Ting ZHANG;
Zhong-Li WANG;
Jian-Long ZHAI;
Yi-Fang GUO

Publication type:

Article

Canagliflozin, a sodium–glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.

Published in:

Journal of Diabetes Investigation, 2019, v. 10, n. 4, p. 933, doi. 10.1111/jdi.13009

By:

Kimura, Yukishige;
Kuno, Atsushi;
Tanno, Masaya;
Sato, Tatsuya;
Ohno, Kouhei;
Shibata, Satoru;
Nakata, Kei;
Sugawara, Hirohito;
Abe, Koki;
Igaki, Yusuke;
Yano, Toshiyuki;
Miki, Takayuki;
Miura, Tetsuji

Publication type:

Article

Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non‐alcoholic fatty liver disease.

Published in:

Journal of Diabetes Investigation, 2019, v. 10, n. 4, p. 1004, doi. 10.1111/jdi.12980

By:

Inoue, Mitsuko;
Hayashi, Akinori;
Taguchi, Tomomi;
Arai, Riina;
Sasaki, Sayaka;
Takano, Koji;
Inoue, Yusuke;
Shichiri, Masayoshi

Publication type:

Article

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial.

Published in:

Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 399, doi. 10.1111/jdi.12888

By:

Feng, Wen‐Huan;
Bi, Yan;
Li, Ping;
Yin, Ting‐Ting;
Gao, Cai‐Xia;
Shen, Shan‐Mei;
Gao, Li‐Jun;
Yang, Dong‐Hui;
Zhu, Da‐Long

Publication type:

Article

Efficacy of canagliflozin combined with antidiabetic drugs in treating type 2 diabetes mellitus: Meta-analysis of randomized control trials.

Published in:

Journal of Diabetes Investigation, 2016, v. 7, n. 3, p. 359, doi. 10.1111/jdi.12417

By:

Meng, Qi;
Shen, Yun;
Liu, Dajin;
Jiang, Fei

Publication type:

Article

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors.

Published in:

2016

By:

Ogawa, Wataru;
Sakaguchi, Kazuhiko

Publication type:

Editorial

Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study.

Published in:

Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 210, doi. 10.1111/jdi.12266

By:

Inagaki, Nobuya;
Kondo, Kazuoki;
Yoshinari, Toru;
Kuki, Hideki

Publication type:

Article

Type Disparity in Sodium–Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study.

Published in:

Cancers, 2024, v. 16, n. 11, p. 2145, doi. 10.3390/cancers16112145

By:

Lin, Tsung-Kun;
Wang, Wei-Yao;
Yang, Tsung-Yuan;
Jong, Gwo-Ping

Publication type:

Article

Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.

Published in:

PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295284

By:

Trentin-Sonoda, Mayra;
Cheff, Véronique;
Gutsol, Alex;
Hébert, Richard L.

Publication type:

Article

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.

Published in:

PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0290603

By:

Dankers, Marloes;
Verlegh, Peeter;
Weber, Karla;
Nelissen-Vrancken, Marjorie;
van Dijk, Liset;
Mantel-Teeuwisse, Aukje

Publication type:

Article

Effect of sodium‐glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin‐treated diabetic dogs.

Published in:

Journal of Veterinary Internal Medicine, 2024, v. 38, n. 3, p. 1353, doi. 10.1111/jvim.17053

By:

Box, Jessica R.;
Oyama, Mark A.;
Mosenco, Ariel S.;
Hess, Rebecka S.

Publication type:

Article

Short‐term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo‐controlled, double‐blind, study.

Published in:

Journal of Veterinary Internal Medicine, 2023, v. 37, n. 6, p. 2520, doi. 10.1111/jvim.16906

By:

Lindåse, Sanna;
Nostell, Katarina;
Forslund, Anders;
Bergsten, Peter;
Bröjer, Johan

Publication type:

Article

Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis.

Published in:

Journal of the American Geriatrics Society, 2016, v. 64, n. 3, p. 543, doi. 10.1111/jgs.14028

By:

Sinclair, Alan J.;
Bode, Bruce;
Harris, Stewart;
Vijapurkar, Ujjwala;
Shaw, Wayne;
Desai, Mehul;
Meininger, Gary

Publication type:

Article

Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial.

Published in:

Diabetes Care, 2024, v. 47, n. 8, p. 1441, doi. 10.2337/dc24-0360

By:

Ware, Julia;
Boughton, Charlotte K.;
Allen, Janet M.;
Wilinska, Malgorzata E.;
Hartnell, Sara;
Thankamony, Ajay;
Randell, Tabitha;
Ghatak, Atrayee;
Besser, Rachel E.J.;
Elleri, Daniela;
Trevelyan, Nicola;
Campbell, Fiona M.;
Sibayan, Judy;
Bailey, Ryan;
Calhoun, Peter;
Dunseath, Gareth;
Hovorka, Roman;
Verhoeven, Vreni;
Thankmonay, Ajay;
Acerini, Carlo

Publication type:

Article

Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study.

Published in:

Diabetes Care, 2024, v. 47, n. 6, p. 933, doi. 10.2337/dc23-1129

By:

Singh, Lakshmi G.;
Ntelis, Spyridon;
Siddiqui, Tariq;
Seliger, Stephen L.;
Sorkin, John D.;
Spanakis, Elias K.

Publication type:

Article

Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143.

Published in:

Diabetes Care, 2024, v. 47, n. 4, p. e35, doi. 10.2337/dc24-0094

By:

Ninon, Foussard;
Alice, Larroumet;
Marie-Amélie, Barbet-Massin;
Laurence, Blanco;
Kamel, Mohammedi;
Thierry, Couffinhal;
Sami, Fawaz;
Yann, Pucheu;
Vincent, Rigalleau

Publication type:

Article

Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143.

Published in:

Diabetes Care, 2024, v. 47, n. 4, p. e34, doi. 10.2337/dc23-2473

By:

Nakasone, Yasuto;
Yamashita, Koh;
Aizawa, Toru

Publication type:

Article

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.

Published in:

Diabetes Care, 2024, v. 47, n. 3, p. 501, doi. 10.2337/dc23-1450

By:

Tobe, Sheldon W.;
Mavrakanas, Thomas A.;
Bajaj, Harpreet S.;
Levin, Adeera;
Tangri, Navdeep;
Slee, April;
Neuen, Brendon L.;
Perkovic, Vlado;
Mahaffey, Kenneth W.;
Rapattoni, Wally;
Ang, Fernando G.

Publication type:

Article

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.

Published in:

Diabetes Care, 2023, v. 46, n. 10, p. 1807, doi. 10.2337/dc23-0492

By:

Moura, Filipe A.;
Berg, David D.;
Bellavia, Andrea;
Dwyer, Jamie P.;
Mosenzon, Ofri;
Scirica, Benjamin M.;
Wiviott, Stephen D.;
Bhatt, Deepak L.;
Raz, Itamar;
Feinberg, Mark W.;
Braunwald, Eugene;
Morrow, David A.;
Sabatine, Marc S.

Publication type:

Article

Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021;44:2419-2426.

Published in:

Diabetes Care, 2022, v. 45, n. 2, p. e37, doi. 10.2337/dc21-1878

By:

Feldman-Billard, Sylvie;
Paques, Michel

Publication type:

Article

Cigarette Smoking as a Predictor of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Genital Infections: A Retrospective Cohort Study.

Published in:

2021

By:

Scoccimarro, Daniele;
Cipani, Giacomo;
Dicembrini, Ilaria;
Mannucci, Edoardo

Publication type:

Letter

Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study.

Published in:

2021

By:

Januzzi Jr., James L.;
Butler, Javed;
Sattar, Naveed;
Xu, Jialin;
Shaw, Wayne;
Rosenthal, Norman;
Pfeifer, Michael;
Mahaffey, Kenneth W.;
Neal, Bruce;
Hansen, Michael K.;
Januzzi, James L Jr

Publication type:

journal article

Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases.

Published in:

2020

By:

Xie, Yan;
Bowe, Benjamin;
Gibson, Andrew K.;
McGill, Janet B.;
Maddukuri, Geetha;
Yan, Yan;
Al-Aly, Ziyad

Publication type:

journal article

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study.

Published in:

2020

By:

Yu, Oriana Hoi Yun;
Dell'Aniello, Sophie;
Shah, Baiju R.;
Brunetti, Vanessa C.;
Daigle, Jean-Marc;
Fralick, Michael;
Douros, Antonios;
Hu, Nianping;
Alessi-Severini, Silvia;
Fisher, Anat;
Bugden, Shawn C.;
Ronksley, Paul E.;
Filion, Kristian B.;
Ernst, Pierre;
Lix, Lisa M.;
Suissa, Samy;
Dormuth, Colin R.;
Hemmelgarn, Brenda R.;
Quail, Jacqueline;
Chateau, Dan

Publication type:

journal article